SERPINH1 promotes malignant progression of laryngeal squamous cell carcinoma via COL7A1-mediated Wnt/β-catenin signaling
Cellular Signalling · 2025
DOI: 10.1016/j.cellsig.2025.112043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2025. Verfasst von Feinan He und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Second Hospital of Jilin University, Department of Otorhinolaryngology, China. Hauptthemen laut MEDLINE: Wnt Signaling Pathway, Laryngeal Neoplasms, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Serpin peptidase inhibitor clade H member 1 (SERPINH1) is implicated in collagen processing and tumor progression, yet its role in laryngeal squamous cell carcinoma (LSCC) remains unclear. This study aimed to elucidate the clinical significance and molecular mechanism of SERPINH1 in LSCC. METHODS: Multi-cohort bioinformatics analysis (TCGA, GEO) identified SERPINH1 as a prognostic marker. SERPINH1 expression was validated in LSCC tissues (IHC, immunofluorescence, Western blot). Functional assays (CCK-8, EdU, Transwell) and xenograft models assessed malignant behaviors. Transcriptomics and co-IP/LC-MS revealed downstream pathways and interactors. Wnt agonist (SKL2001) rescue experiments confirmed pathway dependency. RESULTS: SERPINH1 was overexpressed in LSCC tissues versus adjacent normal and predicted poor survival. SERPINH1 knockdown suppressed proliferation, migration/invasion, and tumor growth in vitro and in vivo. Mechanistically, SERPINH1 bound COL7A1 to stabilize the Wnt/β-catenin signaling complex, reducing β-catenin phosphorylation and enhancing nuclear translocation. Wnt activation via SKL2001 rescued SERPINH1-knockdown phenotypes. CONCLUSION: SERPINH1 drives LSCC progression via COL7A1-mediated Wnt/β-catenin signaling activation. Targeting this axis may offer novel therapeutic strategies for LSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Hospital of Jilin University, Department of Otorhinolaryngology, China.
- The Second Hospital of Jilin University, Department of Otorhinolaryngology, China. Electronic address: tengbo@jlu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
He, F., Li, J., Tong, W., Wang, S., Wang, H., Huang, B., & Teng, B. (2025). SERPINH1 promotes malignant progression of laryngeal squamous cell carcinoma via COL7A1-mediated Wnt/β-catenin signaling. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112043
Vancouver
He F, Li J, Tong W, Wang S, Wang H, Huang B, et al. SERPINH1 promotes malignant progression of laryngeal squamous cell carcinoma via COL7A1-mediated Wnt/β-catenin signaling. Cellular Signalling. 2025. doi:10.1016/j.cellsig.2025.112043
BibTeX
@article{He2025,
author = {He, Feinan and Li, Jinqiu and Tong, Weifang and Wang, Sanchun and Wang, Hongyan and Huang, Baishuo and Teng, Bo},
title = {SERPINH1 promotes malignant progression of laryngeal squamous cell carcinoma via COL7A1-mediated Wnt/β-catenin signaling},
journal = {Cellular Signalling},
year = {2025},
doi = {10.1016/j.cellsig.2025.112043}
}
EUVIMED